House Officer of the year, University of Nebraska Medical Center
Best Fellow poster award at University of Nebraska Dept of Internal Medicine Annual Research Day
Invited to compete in the Endocrine Society’s Presidential Poster Competition for a first-authored top-scoring abstract for presentation at the Annual Meeting & Expo - 2019
College of Medicine, Resident of the Month at University of Nebraska Medical Center
Severe Systemic Inflammatory Response Syndrome with Multi Organ Failure following Zoledronic Acid Infusion. Jan 2018. AACE Clinical Case Reports, https://doi.org/10.4158/EP161734.CR
Tumor Induced Osteomalacia: 68GA-DOTATATE PET/CT scan for Localization. Journal of Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-499, https://doi.org/10.1210/js.2019-MON-499
Has Technology Improved Diabetes Management in Relation to Age, Gender, and Ethnicity? Current Diabetes Reports 2019 19:111, https://doi.org/10.1007/s11892-019-1231-5
A Retrospective Study of Glucagon Like Peptide-1 Receptor Agonists for the Management of Diabetes after Transplantation. Diabetes Ther. 2020;11(4):987‐994,https://doi.org/10.1007/s13300-020-00786-1
Trabecular Bone Score and Transilial Bone Trabecular Histomorphometry in Type 1 Diabetes and Healthy Controls. Bone. Aug 2020;137:115451, https://doi.org/10.1016/j.bone.2020.115451
Predictability of Diabetes Mellitus Type 2 Remission and changes in Metabolic Profile after Bariatric Surgery using DiaRem scoring system AACE 2017
Role of Thromboxane-Prostanoid Receptor in Obesity related Insulin resistance. American Diabetes Association. 79th Scientific congress 2019
Thromboxane Signaling and Obesity-Related Insulin Resistance. American Diabetes Association. 80th Scientific Congress 2020
A Rare Case of Carcinoid Heart Disease without Hepatic Metastasis. ACP, Illinois Chapter, 2007
Fracture Liaison Service: Endocrinology embedded in an Orthopedic Trauma Service
Body composition changes in US veterans with Obesity during treatment with different weight loss medications when added to aggressive lifestyle intervention. Ongoing study
SELECT - Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity. Ongoing clinical trial